KAYLA COMPTON: Open Payments
NPI 1588441380 · GRANBURY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,026 in 96 payments from 12 companies in 2025. Trend: 2023 $41 · 2024 $1,600 · 2025 $2,026
Food & beverage: $1,941Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $728 |
| Janssen Biotech, Inc. | 16 | $304 |
| Aimmune Therapeutics, Inc. | 9 | $223 |
| Phathom Pharmaceuticals, Inc. | 4 | $195 |
| Ardelyx, Inc. | 6 | $132 |
| QOL Medical, LLC | 4 | $131 |
| Lilly USA, LLC | 3 | $77 |
| Intercept Pharmaceuticals, Inc. | 5 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $75 |
| Madrigal Pharmaceuticals | 3 | $53 |
Products named: TREMFYA, SKYRIZI, ZENPEP, VOQUEZNA, RINVOQ, LINZESS, IBSRELA, Sucraid.
Industry payments across TX — which companies pay providers there.
